Kirsten White, PhD, is a Senior Director of Clinical Virology at Gilead Sciences. Dr. White has spent the last 20 years investigating drug mechanisms of action individually and in combination and the development and archiving of resistance substitutions to HIV antiretrovirals. She has worked on the development of many single tablet regimens to improve the lives of people living with HIV. “I hope to continue to help people through developing newer antiretrovirals with fewer side effects and even easier dosing strategies while maintaining viral suppression.”
